Rev activity determines sensitivity of HIV-1-infected primary T cells to CTL killing.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Immunity

• Publication date

  2003-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S1074-7613(03)00031-1PMID 12594955
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes

  2002cited by this paper
• Nef-Mediated Resistance of Human Immunodeficiency Virus Type 1 to Antiviral Cytotoxic T Lymphocytes

  2002cited by this paper
• Infection of the CD45RA+ (Naive) Subset of Peripheral CD8+ Lymphocytes by Human Immunodeficiency Virus Type 1 In Vivo

  2001cited by this paper
• Characterization of the HIV-1-Specific T-Helper Cell Response

  2001cited by this paper
• Efficient Class I Major Histocompatibility Complex Down-Regulation by Simian Immunodeficiency Virus Nef Is Associated with a Strong Selective Advantage in Infected Rhesus Macaques

  2001cited by this paper
• The AG recombinant IbNG and novel strains of group M HIV-1 are common in Cameroon.

  2001cited by this paper
• Challenges and opportunities for development of an AIDS vaccine

  2001cited by this paper
• Modulation of Different Human Immunodeficiency Virus Type 1 Nef Functions during Progression to AIDS

  2001cited by this paper
• Diverse BF recombinants have spread widely since the introduction of HIV-1 into South America

  2001cited by this paper
• Skewed maturation of memory HIV-specific CD8 T lymphocytes

  2001cited by this paper
• The HIV-1 regulatory proteins Tat and Rev are frequently targeted by cytotoxic T lymphocytes derived from HIV-1-infected individuals.

  2001cited by this paper
• Analysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus

  2000cited by this paper
• HIV-Specific Cd8+ T Cells Produce Antiviral Cytokines but Are Impaired in Cytolytic Function

  2000cited by this paper
• HIV's evasion of the cellular immune response

  1999cited by this paper
• Molecular Cloning and Phylogenetic Analysis of Human Immunodeficiency Virus Type 1 Subtype C: a Set of 23 Full-Length Clones from Botswana

  1999cited by this paper
• Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection.

  1999cited by this paper
• A Cell Line-Based Neutralization Assay for Primary Human Immunodeficiency Virus Type 1 Isolates That Use either the CCR5 or the CXCR4 Coreceptor

  1999cited by this paper
• Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes.

  1999cited by this paper
• Analysis of a successful immune response against hepatitis C virus.

  1999cited by this paper
• HIV transcriptional activation by the accessory protein, VPR, is mediated by the p300 co-activator.

  1998cited by this paper
• A Comprehensive Panel of Near-Full-Length Clones and Reference Sequences for Non-Subtype B Isolates of Human Immunodeficiency Virus Type 1

  1998cited by this paper
• Apoptosis of CD8+ T cells is mediated by macrophages through interaction of HIV gp120 with chemokine receptor CXCR4

  1998cited by this paper
• Costimulation of Naive CD8+ Lymphocytes Induces CD4 Expression and Allows Human Immunodeficiency Virus Type 1 Infection

  1998cited by this paper
• The HIV-1 Rev protein.

  1998cited by this paper
• HIV-1 regulatory/accessory genes: keys to unraveling viral and host cell biology.

  1998cited by this paper
• HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes

  1998cited by this paper
• Antiviral pressure exerted by HIV-l-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus

  1997cited by this paper
• Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS

  1997cited by this paper
• Evasion of Cytotoxic T Lymphocyte (CTL) Responses by Nef-dependent Induction of Fas Ligand (CD95L) Expression on Simian Immunodeficiency Virus–infected Cells

  1997cited by this paper
• Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection.

  1997cited by this paper
• Upregulation of Fas Ligand by Simian Immunodeficiency Virus—A nef-arious Mechanism of Immune Evasion?

  1997cited by this paper
• CD4 down-modulation during infection of human T cells with human immunodeficiency virus type 1 involves independent activities of vpu, env, and nef

  1996cited by this paper
• Immunology Taught by Viruses

  1996cited by this paper
• Functional consequences of natural sequence variation in the activation domain of HIV-1 Rev.

  1996cited by this paper
• Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes

  1996cited by this paper
• Changes in the viral mRNA expression pattern correlate with a rapid rate of CD4+ T-cell number decline in human immunodeficiency virus type 1-infected individuals

  1995cited by this paper
• Persistence of attenuated rev genes in a human immunodeficiency virus type 1-infected asymptomatic individual

  1995cited by this paper
• Human immunodeficiency virus type 1 cellular RNA load and splicing patterns predict disease progression in a longitudinally studied cohort

  1995cited by this paper
• Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1

  1994cited by this paper
• Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones.

  1992cited by this paper
• Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: identification of replication-competent and -defective viral genomes

  1991cited by this paper
• Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition

  1991cited by this paper
• Independent fluctuation of human immunodeficiency virus type 1 rev and gp41 quasispecies in vivo

  1991cited by this paper
• Cells nonproductively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: a molecular model for latency.

  1990cited by this paper
• Replication of HIV-1 in primary monocyte cultures.

  1990cited by this paper
• Site-directed mutagenesis of two trans-regulatory genes (tat-III,trs) of HIV-1.

  1988cited by this paper
• Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus

  1978cited by this paper

• Rev-RRE activity modulates HIV-1 replication and latency reactivation: Implications for viral persistence and cure strategies

  2025cites this paper
• Rev-RRE activity modulates HIV-1 replication and latency reactivation: Implications for viral persistence and cure strategies

  2025cites this paper
• Measurement of HIV Rev-Rev Response Element Functional Activity.

  2024cites this paper
• Rev–Rev Response Element Activity Selection Bias at the Human Immunodeficiency Virus Transmission Bottleneck

  2023influential citation
• Rev-Rev Response Element Activity Selection Bias at the HIV Transmission Bottleneck

  2023cites this paper
• HIV-1 Rev-RRE functional activity in primary isolates is highly dependent on minimal context-dependent changes in Rev

  2022cites this paper
• Infections that cause secondary immune deficiency

  2020cites this paper
• Sequence and Functional Variation in the HIV-1 Rev Regulatory Axis.

  2020cites this paper
• Structural Fluidity of the Human Immunodeficiency Virus Rev Response Element

  2020cites this paper
• Evolution of the HIV-1 Rev Response Element during Natural Infection Reveals Nucleotide Changes That Correlate with Altered Structure and Increased Activity over Time

  2019cites this paper
• 1 An assay to measure the activity of RNA elements and proteins that promote the expression of 1 mRNA with retained introns . 2 3

  2019cites this paper
• A novel retroviral vector system to analyze expression from mRNA with retained introns using fluorescent proteins and flow cytometry

  2019cites this paper
• Evolution of the HIV-1 RRE during natural infection reveals key nucleotide changes that correlate with altered structure and increased activity over time

  2018cites this paper
• Recent advancement to prevent the development of allergy and allergic diseases and therapeutic strategy in the perspective of barrier dysfunction.

  2018cites this paper
• Probiotics in Asthma and Allergy Prevention

  2017cites this paper
• Rev–RRE Functional Activity Differs Substantially Among Primary HIV-1 Isolates

  2016cites this paper
• The HIV-1 Rev response element (RRE) adopts alternative conformations that promote different rates of virus replication

  2015cites this paper
• Targeting HIV latency: resting memory T cells, hematopoietic progenitor cells and future directions

  2014cites this paper
• STRATAGIES FOR DEVELOPING VACCINES FOR HIV/AIDS. (REVERSE VACCINOLOGY)

  2014cites this paper
• Limited Nucleotide Changes in the Rev Response Element (RRE) during HIV-1 Infection Alter Overall Rev-RRE Activity and Rev Multimerization

  2013cites this paper
• HIV-1 Rev multimerization: mechanism and insights.

  2013cites this paper
• Genetic Analysis of Rev Variation in Equine Infectious Anemia Virus

  2012cites this paper
• Rev Variation during Persistent Lentivirus Infection

  2011influential citation
• DDX1 Is an RNA-Dependent ATPase Involved in HIV-1 Rev Function and Virus Replication

  2011cites this paper
• Influence of the exogenous virus HIV-1 on the expression of human endogenous retroviral elements (HERVs)

  2011cites this paper
• Novel Nipah Virus Immune-Antagonism Strategy Revealed by Experimental and Computational Study

  2010cites this paper
• Control of HIV replication in astrocytes by a family of highly conserved host proteins with a common Rev-interacting domain (Risp)

  2010cites this paper
• Molecular and biological characterization of equine infectious anemia virus Rev.

  2010cites this paper
• Innovative approaches to develop prophylactic and therapeutic vaccines against HIV/AIDS.

  2009cites this paper
• Transient Nature of Long-Term Nonprogression and Broad Virus-Specific Proliferative T-Cell Responses with Sustained Thymic Output in HIV-1 Controllers

  2009cites this paper
• Establishment and Characterization of THP-1 Cell Model Stably Expressing HIV-1 Auxiliary Protein Rev: Establishment and Characterization of THP-1 Cell Model Stably Expressing HIV-1 Auxiliary Protein Rev

  2008cites this paper
• Molecular mechanisms of HIV-1 vertical transmission and pathogenesis in infants.

  2008cites this paper
• Naturally arising point mutations in non-essential domains of equine infectious anemia virus Rev alter Rev-dependent nuclear-export activity.

  2008influential citation
• Protein structure and oligomerization are important for the formation of export‐competent HIV‐1 Rev–RRE complexes

  2008cites this paper
• Treatment of Staphylococcus aureus infections: new issues, emerging therapies and future directions

  2007cites this paper
• Problems and emerging approaches in HIV/AIDS vaccine development

  2007cites this paper
• Régulation de l’activité de la protéine Rev du HIV-1 par des modifications post-traductionnelles et inhibition de sa fonction par des peptides actifs à partir du milieu extracellulaire

  2006cites this paper
• Expression of human immunodeficiency virus type 1 tat from a replication-deficient herpes simplex type 1 vector induces antigen-specific T cell responses.

  2006cites this paper
• PRMT6 diminishes HIV-1 Rev binding to and export of viral RNA

  2006cites this paper
• Human Immunodeficiency Virus Type 1 Nef Domains Required for Disruption of Major Histocompatibility Complex Class I Trafficking Are Also Necessary for Coprecipitation of Nef with HLA-A2

  2005cites this paper
• MOLECULAR MECHANISMS OF HIV-1 INFECTION: ENTRY, POST-ENTRY, AND GENE EXPRESSION

  2005cites this paper
• The humoral immune response to HIV-1: Consequences for vaccine design.

  2005cites this paper
• Recombinant BCG expressing HIV-1 C GAG : selection of the vaccine gene and construction and evaluation as a vaccine candidate

  2005cites this paper
• Evaluations of HIV Type 1 rev Gene Diversity and Functional Domains Following Perinatal Transmission

  2005cites this paper
• Nonstructural HIV proteins as targets for prophylactic or therapeutic vaccines.

  2004cites this paper
• Characterization of Rev variants selected during chronic and inapparent stages of equine infectious anemia virus infection

  2004influential citation
• An age-structured model of hiv infection that allows for variations in the production rate of viral particles and the death rate of productively infected cells.

  2004cites this paper
• Resistance of HIV-infected cells to cytotoxic T lymphocytes.

  2004cites this paper
• Kinetics of Virus-Specific CD8 (cid:1) T Cells and the Control of Human Immunodeficiency Virus Infection

  2004cites this paper
• Kinetics of Virus-Specific CD8+ T Cells and the Control of Human Immunodeficiency Virus Infection

  2004cites this paper
• Prospects for an AIDS vaccine: three big questions, no easy answers.

  2004cites this paper
• Migration ofAntigen-Specific T Cells Away from CXCR4-Binding Human ImmunodeficiencyVirus Type 1gp120

  2004cites this paper
• Virus Evasion of MHC Class I Molecule Presentation1

  2003cites this paper
• In Brief

  2003cites this paper
• HIV: REVealing HIV

  2003cites this paper
• Subpopulations of Equine Infectious Anemia Virus Rev Coexist In Vivo and Differ in Phenotype

  2003cites this paper